Audubon, PA, United States of America

Simon Tasker

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Bpsi Holdings, Inc.. Active years: 2010.


% Patents Active = 100.0


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Simon Tasker: Innovator in Enteric Coatings

Introduction

Simon Tasker is a notable inventor based in Audubon, PA (US). He has made significant contributions to the field of pharmaceutical technology, particularly in the development of enteric coatings for orally ingestible substrates. His innovative work has the potential to enhance the effectiveness of various dietary supplements and medications.

Latest Patents

Simon Tasker holds a patent for "Enteric coatings for orally ingestible substrates." This patent describes enteric film coating systems designed for pharmaceutical tablets and dietary supplements. The preferred aspects of his invention include an ethylcellulose dispersion combined with a substantially gastro-insoluble pore former, such as sodium alginate. This innovative approach aims to improve the delivery and absorption of active ingredients in the gastrointestinal tract.

Career Highlights

Throughout his career, Simon Tasker has demonstrated a commitment to advancing pharmaceutical technologies. His work at Bpsi Holdings, Inc. has positioned him as a key player in the development of enteric coating systems. With a focus on improving patient outcomes, he continues to explore new avenues for innovation in this critical area of health.

Collaborations

Simon has collaborated with notable colleagues, including Kurt A. Fegely and Lawrence Martin. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the impact of their work in the field.

Conclusion

In summary, Simon Tasker is a dedicated inventor whose work in enteric coatings has the potential to revolutionize the way orally ingestible substrates are formulated. His innovative contributions continue to shape the future of pharmaceutical technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…